Category Ranking
98%
Total Visits
921
Avg Visit Duration
2 minutes
Citations
20
Article Abstract
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4803086 | PMC |
| http://dx.doi.org/10.1164/rccm.201509-1872LE | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Assessing the promoter variant in a large cohort of systemic sclerosis-associated interstitial lung disease.
RMD Open
August 2025
Department of Cell Biology and Immunology, Institute of Parasitology and Biomedicine Lopez-Neyra, CSIC, Granada, Spain
Objective: The common gain-of-function variant rs35705950, located in the promoter of gene, has been strongly associated with interstitial lung diseases (ILDs) of different aetiology, such as idiopathic pulmonary fibrosis (IPF) and rheumatoid arthritis-associated ILD (RA-ILD). In this study, we aimed to investigate the association of this variant and its nearby single nucleotide polymorphisms (SNPs) in the largest cohort of systemic sclerosis-associated ILD (SSc-ILD) to date.
Methods: Samples were collected from blood/saliva, followed by DNA extraction and genotyping using SNP arrays.
Association of the promoter polymorphism with idiopathic pulmonary fibrosis in a lebanese cohort.
Front Genet
June 2025
Department of Pulmonology and Critical Care, Hotel Dieu de France Hospital, Beirut, Lebanon.
Background And Objective: Idiopathic Pulmonary Fibrosis (IPF) is an interstitial lung disease that causes irreversible alterations in the architecture of the lung parenchyma, leading to impaired ventilation. Both environmental factors and genetic predisposition play significant roles in the development of IPF. A single nucleotide polymorphism (SNP) (rs35705950) within the promoter of the mucin 5B gene ( has been reported to be associated with the disease; however, no data is available from Lebanon or the Middle East.
View Article and Find Full Text PDFThe MUC5B promoter variant results in proteomic changes in the nonfibrotic lung.
JCI Insight
July 2025
Division of Pulmonary Sciences and Critical Care Medicine, and.
The gain-of-function MUC5B promoter variant is the dominant risk factor for the development of idiopathic pulmonary fibrosis (IPF). However, its impact on protein expression in both nonfibrotic control and IPF lung specimens has not been well characterized. Utilizing laser capture microdissection coupled to mass spectrometry, we investigated the proteomic profiles of airway and alveolar epithelium in nonfibrotic controls (n = 12) and IPF specimens (n = 12), stratified by the MUC5B promoter variant.
View Article and Find Full Text PDFTrends and hotspots in pulmonary fibrosis biomarker research: a bibliometric analysis.
Front Med (Lausanne)
April 2025
Department of Pulmonary and Critical Care Medicine, Zhangjiajie Hospital Affiliated to Hunan Normal University, Zhangjiajie, Hunan, China.
Background: Pulmonary fibrosis is a fatal disease characterized by progressive scarring of lung tissue, with a complex pathogenesis and limited therapeutic options. The identification of robust biomarkers is critical for addressing key clinical challenges, including delayed diagnosis and poor prognostic assessment.
Methods: This study systematically analyzes global research trends and emerging hotspots in pulmonary fibrosis biomarkers by examining literature from 2001 to 2024 indexed in the Web of Science Core Collection.
Genetic underpinning of idiopathic pulmonary fibrosis: the role of mucin.
Expert Rev Respir Med
February 2025
Department of Medicine, University of Colorado Denver, School of Medicine, Aurora, CO, USA.
Introduction: Idiopathic pulmonary fibrosis (IPF) is a chronic lung disease characterized by progressive scarring and reduced survival. The development of IPF is influenced by rare and common genetic variants, cigarette smoking, aging, and environmental exposures. Among the two dozen genetic contributors, the MUC5B promoter variant (rs35705950) is the dominant risk factor, increasing the risk of both familial and sporadic IPF and accounting for nearly 50% of the genetic predisposition to the disease.
View Article and Find Full Text PDF